Non-small cell lung cancer market value in Aisa-Pacific region to touch $2.9 ... pharmabiz.com The GBI Research has reviled that the non-small cell lung cancer (NSCLC) therapeutics market value in the Asia-Pacific (APAC) region ā Australia, China, India and Japan ā is likely to increase at CAGR of 6.3 per cent during 2012-2019 to $2.9 billion ... |
